FDA Approves Qulipta for Chronic Migraine

The FDA expanded the indication for Qulipta for the preventive treatment of migraine in adults.

APRIL 18, 2023

AAN Issues Guidelines for Pediatric Migraine Treatment

New guidelines issued for pediatric migraine management. Looks at managing both acute migraine and preventive ...

AUGUST 15, 2019

FDA Approves First Treatment for Episodic Cluster Headache

People with episodic cluster headache represent 85% to 90% of cluster headache prevalence, with approximately ...

JUNE 5, 2019

FDA Approves Emgality for Migraine Prevention

The FDA approved galcanezumab-gnlm (Emgality, Eli Lilly) to prevent migraine in adults. 

SEPTEMBER 28, 2018